Venetoclax Combined With Azactidine in the Treatment of ALAL

Clinical trial NCT05901974 · RECRUITING

Trial details

NCT number: NCT05901974
Sponsor: Sheng-Li Xue, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Leukemia of Ambiguous Lineage

Start date: 2023-07-01
Primary completion: 2026-03-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.